Drugs Information:
Vismodegib
Basic Information
|
||
ID | DDInter1940 | |
Drug Type | small molecule | |
Molecular Formula | C19H14Cl2N2O3S | |
Molecular Weight | 421.297 | |
CAS Number | 879085-55-9 | |
Description | Vismodegib inhibits the hedgehog signalling pathway and is indicated for treatment of adult basal cell carcinoma. FDA approved on Jan 30, 2012. | |
ATC Classification | L01XJ01 | |
IUPAC Name | 2-chloro-N-[4-chloro-3-(pyridin-2-yl)phenyl]-4-methanesulfonylbenzamide | |
InChI | BPQMGSKTAYIVFO-UHFFFAOYSA-N | |
Canonical SMILES | CS(=O)(=O)C1=CC(Cl)=C(C=C1)C(=O)NC1=CC=C(Cl)C(=C1)C1=CC=CC=N1 | |
Useful Links | DrugBank ChEBI PubChem Substance KEGG Drug ChemSpider BindingDB PharmGKB Wikipedia ChEMBL ZINC |
Interactions with
Vismodegib
Filter:
Severity level | ID | Name | Mechanism | Detail |
---|
Interactions with diseases
Filter:
Severity level | Disease name | Text | References |
---|
Interactions with foods
Filter:
Severity level | Food name | Description | Management | Mechanism | References |
---|
Interactions with compound preparation
Multi-DRUG trade | Multi-DRUG | Drug type | Warning | Note |
---|